All posts by admin2

Is it All Coming Together for Cannabis Strategic Ventures (OTCMKTS:NUGS)?

Is it All Coming Together for Cannabis Strategic Ventures (OTCMKTS:NUGS)?

The drumbeat is getting louder. Can you hear it? We can’t hear anything else. It sounds like this: “Pot Stocks! Pot Stocks! Pot Stocks!” And on and on.

Check out the marijuana ETF (ticker: MJ). Check out Aurora (ACB) or Tilray (TLRY). Check out GRWG making new all-time highs this month. Check out the AdvisorShares Pure US Cannabis ETF (MSOS). The whole space is skying.

That means it’s time to start to digging around for unappreciated and excessively promising stories – the overlooked plays in the space that haven’t gotten the same fanfare, but may start to draw attention. That’s where the opportunity may be at this point.

And, with that in mind, our attention turns to Cannabis Strategic Ventures (OTCMKTS:NUGS), an interesting story on the OTC as a rapidly growing and potentially underappreciated cannabis stock with strong metrics and signs of increasingly productive positioning in the ecosystem of the booming California cannabis market.

The story for NUGS right now is about timing, luck, and execution – and raw numbers that tell a story of performance that can’t be easily dismissed.

Firing on All Cylinders

It was easy to look away from the cannabis market earlier this year after the pandemic got going at full blast. And, it turns out, most companies in that space seem to have done just that, with reduced headcounts, lowered production, and chopped investments in capacity and innovation.

The result was an undersupplied market for cannabis that hit the end market as an actual shortage in many places in May and June.

But Cannabis Strategic Ventures (OTCMKTS:NUGS) was one of the few players that went the other direction, stepping up its investment, driving increased product quality, and adding to its production capacity as its competitors were pulling back.

It was a contrarian bet that has paid off in a big way, but investors and market participants don’t seem to realize it yet, suggesting there may be an opportunity here.

Our thesis is that this type of contrarian bet doesn’t just lead to a short-term burst in superficial growth rate – by stepping into the gap in the market. But it leads to a sticky upgrade in market positioning as end market retailers come to rely on a new a reliable source of high-quality goods when the context is one of scarcity.

The Big Point

That has a long-term impact on relationships. We would argue that we have seen precisely that type of transition for Cannabis Strategic Ventures (OTCMKTS:NUGS) so far this year.

If you look back through the company’s releases so far in 2020 and at the close of last year, you will see the following the sequence: a projection about revenues late last year looking for “$5 million in 2020 sales related to cannabis products”, a better than expected push to start the year, a series of investments in expanded production capacity and improved product quality, reports of increased pricing out the door on a per-unit volume basis for production, increased output as capacity increases start to pay off, and an unmistakable trend in sales growth across basically every conceivable period-to-period comparison.

Now, here we sit with results crushing guidance and every sign that the company has made undeniable progress in execution and market positioning in a sector with widely understood cyclical tailwinds in a massive structural growth boom.

Long story short: Cannabis Strategic Ventures (OTCMKTS:NUGS) ticks all the boxes right now and should be worth a closer look.

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click here. In addition, this article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

Published at Mon, 09 Nov 2020 07:38:19 +0000

Opponents Plan to File Lawsuit Over Montana’s Cannabis Legalization Initiative

Opponents Plan to File Lawsuit Over Montana’s Cannabis Legalization Initiative

Updated: 8:49 a.m. Eastern Standard Time, Nov. 5 

As Election 2020 results continue to pour in across the U.S., we are monitoring cannabis-related down-ballot races in several states.  

California 

Unofficial election results show Costa Mesa, Calif., voters are in favor of allowing adult-use cannabis dispensaries and delivery services; and Laguna Woods, voters support that city allowing dispensaries. A measure in La Habra to permit “up to four cannabis delivery licenses” received more “yes” than “no” votes.

Ventura County, Calif., voters said “yes” to Measure O. ” The Ventura County Star reported Oct. 3, “The initiative on the Nov. 3 ballot allows up to 500 acres of cultivation of cannabis in greenhouses and 100 acres in nurseries in certain unincorporated areas.”

Patch has reported preliminary voting results out of Banning, Calif., favoring a tax on cannabis distribution businesses. The “gross receipts tax — capped at 10 percent” will go toward 911-emergency services.  

And Calabasas, Calif., a city that doesn’t currently allow cannabis dispensaries, is likely to approve an ordinance that would impose a tax on cannabis business, according to Patch.  

As the ordinance states, the 10% tax would be imposed “on the privilege of conducting the following activities within the city’s jurisdiction: transporting, dispensing, manufacturing, producing, processing, preparing, storing, testing, providing, donating, selling, or delivering, or distributing cannabis, cannabis products, cannabis accessories, or cannabinoid preparations delivering, or distributing cannabis, cannabis products, cannabis accessories, or cannabinoid preparations … in the City of Calabasas, under the Control, Regulate and Tax Adult Use of Marijuana Act and the Medicinal and Adult Use Cannabis Regulation and Safety Act (California Business and Professions Code sections 26000, et seq.) ….” 

In Jurupa Valley, Calif., a measure designed to affect changes that would bolster city revenue from cannabis sales, was rejected by voters in a vote of 6,543 to 6,139, according to final election results posted on The Press Enterprise.  

A citizen-led initiative in 2018 permitted adult-use cannabis sales, “But city officials said the 2018 law has generated little revenue for municipal coffers,” according to The Press Enterprise

Measure U – City Of Jurupa Valley Tax Increase On Cannabis Businesses For General Municipal Services “would boost marijuana tax dollars while allowing as many as nine stores, or dispensaries — up from the current ceiling of seven,” The Press Enterprise reported. “Measure U would let the city council set the tax rate as high as 6%. Jurupa Valley officials estimated the tax could bring in $2 million to $3 million per year. Existing marijuana stores would be allowed to continue operating under Measure U, and a lottery would be established to determine who gets licenses to open new cannabis shops.” 

Colorado 

Three Colorado cities voted to legalize adult-use cannabis sales, according to preliminary election data.  

Voters in Littleton, Colo., voted to allow adult-use cannabis sales, according to early election results Nov. 3, reported Colorado Community Media.  

“Voters approved Ballot Question 300, allowing the city’s three medical marijuana dispensaries to begin recreational sales, with 64.6% of the vote in the first round of election results at 7 p.m. on Nov. 3,” according to the report. “The vote ends years of opposition to retail sales from city council, which first banned retail marijuana sales in 2014, after Colorado voters passed Amendment 64. That statewide measure, which also passed in Littleton, established a constitutional right to possess marijuana for personal use, but allowed municipalities to regulate whether sales were allowed.” 

Voters in Lakewood, Colo., also voted to allow adult-use cannabis sales. The language for Ballot Question 2B, which was voted in by a vote of 66.02% to 33.98%, asked voters whether the City of Lakewood should “adopt an ordinance adopting regulations governing the operation of retail marijuana stores and retail marijuana cultivation facilities.”  

And voters in Buena Vista, Colo., approved retail cannabis sales in a vote of 54.88% to 45.12% as well as a cannabis sales tax in a vote of 66.14% to 33.86%, according to the Heart of the Rockies Radio.

Voters in Broomfield County, Colo., passed Ballot Question 2A, 59.56% to 40.44%. The measure says the city and county of Broomfield will place a new 4% sales tax on adult-use cannabis and cannabis “products” and “dispensaries” “if the prohibitionon retail marijuana stores is allowed to expire on February 1, 2021.” Broomfield City Council can increase the tax but not to more than 10%.

Illinois 

Seven Chicago suburbs have voted on whether to allow adult-use cannabis sales, according to the Chicago Tribune. These are the unofficial results with all precincts reporting: 

A few hundred miles south, voters in Murphysboro, Ill., voted Nov. 3 to allow adult-use cannabis sales in the city, reversing a previous vote by city leaders to ban adult-use cannabis, according to WSIL TV. As WSIL reported, now that the advisory question has passed, “The city of Murphysboro will now determine how to move forward with marijuana businesses in town.” 

Maine 

In Maine, voters in the towns of Surry and Southwest Harbor have expressed their support to allow adult-use cannabis retail businesses, according to The Ellsworth American. These are the first municipalities in Hancock County to allow adult-use retail. 

The news outlet said the vote was particularly close in Surry, with 572 people voting for and 504 people voting against allowing the businesses. 

To the southwest, in Portland, Maine, a measure to scrap the city’s 20-retail-store cap and allow dispensaries to be closer together passed with roughly 53% of the vote, according to the Portland Press Herald

Maine legalized adult-use cannabis through a 2016 ballot initiative; however, municipalities must opt in to the program, and legal sales in communities that opted in didn’t begin until Oct. 9 this year. The adult-use program was initially delayed when former Gov. Paul LePage in November 2017 vetoed a bill that, if signed into law, would have taxed and regulated recreational cannabis. “On May 2, 2018, the Legislature overrode the Governor’s veto of LD 1719, An Act to Implement a Regulatory Structure for Adult Use Marijuana,” according to the Government of Maine’s website. A regulatory structure was finally signed into law by Gov. Janet Mills on June 27, 2019, per the government report. 

Michigan 

Voters in Pinckney, Livingston County, Mich., on Nov. 3, ended a ban on marijuana businesses, according to Livingston Daily. The ban had followed adult-use legalization in the state; Michigan voters’ approved Proposal 1, which legalized adult-use marijuana for people age 21 or older, in November 2018. As Livingston Daily reported:  

“Pinckney will be the first municipality in Livingston County to allow marijuana businesses after voters approved a proposal to end a ban on such establishments. 

Voters approved the measure, 54.3% to 45.7%. It passed by 117 votes, with 743 votes in favor of the proposal and 626 against it.”

Michigan’s Kawkawlin Township (Bay County) said no to adult-use cannabis. Voters there rejected by a marginal vote of 1,537 to 1,149 a proposal to nullify the township board’s previous decision to opt out of adult-use cannabis business under the Michigan Regulation and Taxation of Marihuana Act and to allow an unlimited number of adult-use licenses in the township, according to MLive.com.  

Oregon

Voters in Sherwood, Ore., approved a measure to end the prohibition on recreational cannabis facilities with 54% voting in favor. “I think it is great that voters of Sherwood have voted to allow adult use cannabis retailers to open shop,” Jesse Bontecou, director of membership service for The Oregon Retailers of Cannabis Association, says. “They have shown once again people love cannabis and the legal jobs and taxes it generates for communities. Cannabis legalization is here to stay locally and nationally!” 

Meanwhile, residents of Winston, Ore., rejected a measure to ease zoning restrictions on cannabis retailers, while voting in favor of an additional 3% sales tax for items sold at existing retailers.  

Also, Deschutes County residents rejected a measure that would have allowed new cannabis producers, processors and processing sites to be located in unincorporated areas.  

Cannabis Business Times and Cannabis Dispensary Senior Editor Brian MacIver contributed reporting.

Published at Thu, 05 Nov 2020 16:55:00 +0000

Cannabis and CBD Stocks on Election Watch (YCBD, CBGL, MJNA)

Cannabis and CBD Stocks on Election Watch (YCBD, CBGL, MJNA)

Who won? It’s pretty clear: Cannabis, Hemp, and CBD.

The sticky plant was legalized on all grounds in Arizona, Montana, New Jersey, and South Dakota. The most important piece of this story is really about the crossover along cultural lines – three of these four states qualify as canaries in the coalmine for national legalization by extrapolation as the cannabis plant becomes accepted and mobilized around product development and distribution on a mainstream, bipartisan basis.

It’s just a matter of time.

With that in mind, we take a look at a few of the more active and interesting stocks with direct exposure to the CBD theme, including: cbdMD Inc (NYSEAMERICAN:YCBD), Cannabis Global Inc (OTCMKTS:CBGL), and Medical Marijuana Inc (OTCMKTS:MJNA).

cbdMD Inc (NYSEAMERICAN:YCBD) is perhaps the top-tier player in the pure-play CBD space. The company promulgates itself as a company that produces and distributes various cannibidiol (CBD) products.

It owns and operates the consumer hemp-based CBD brand, cbdMD. The company’s product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name. The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States.

cbdMD Inc (NYSEAMERICAN:YCBD) just announced that the company was proud to support MMA champion Daniel “DC” Cormier, a premier member of “Team cbdMD”, which is the CBD industry’s premier athletic sponsorship program, as he prepares for the fight of his career. This past Saturday, August 15, 2020, Cormier headlined a primetime MMA showdown against heavyweight champ Stipe Miocic in a highly anticipated ‘rubber match’. ‘Miocic vs. Cormier 3’ aired live at 10 PM ET (ESPN+ PPV) from the UFC APEX facility in Las Vegas.

“My mind is ready, and my body is ready to do something great. This fight is the build-up of years of hard work and preparation. Thousands of hours on the mat and endless amounts of time training. This fight means everything to me, literally everything. And I am so thankful for cbdMD and put my trust in their CBD ‘Recover’ Inflammation Cream, CBD bath bombs, and CBD gummies to help me get ready for this major fight,” said Cormier.

Even with that news, the action hasn’t really heated up in the stock, with shares moving net sideways over the past week. Shares of the stock have powered higher over the past month, rallying roughly 7% in that time on strong overall action.

cbdMD Inc (NYSEAMERICAN:YCBD) managed to rope in revenues totaling $10.6M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 32.2%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($15.1M against $4.4M).

Cannabis Global Inc (OTCMKTS:CBGL) continues to make progress. This is one of the most interesting names in the CBD space given its strong IP backing – with more than a half dozen provisional patents in process at the USPTO – and its innovative movement toward non-CBD cannabinoid production technology.

This includes beverages, a range of CBD products, explorations into exotic cannabinoids, and its line of Hemp You Can Feel™ products, which now include both alcohol substitute cocktail mixers and a range of infused sweeteners.

Cannabis Global Inc (OTCMKTS:CBGL) recently announced the filing of a new patent application resulting from its Project Varin research program. The application addresses new methods for the creation of highly bioavailable and ultra-fast acting cannabinoids for use in beverages, food, topical, and other applications. The non-provisional application expands on the developments and technologies outlined in the provisional applications that were filed on November 4, 2019.

According to the release, the Company believes this technology is revolutionary, holding the potential to rewrite the efficacy and cost equations in the cannabis industry. Additionally, the technology will allow for significantly faster onset of active cannabinoids ingredients, which are expected to be experienced in minutes, versus oftentimes in hours for current generations of cannabinoid infusion technologies.

“We believe what we have created is highly significant to the cannabis industry, especially as nationwide cannabis legalization looms on the horizon,” commented Arman Tabatabaei, CEO of Cannabis Global. “This new cannabinoid delivery system is designed to allow beverage, food, and cosmetic product formulators to use significantly less cannabinoids in products while achieving similar or meaningfully greater efficacy. Our patent filing covers not only the new processes developed to create the new forms of cannabinoids but also the nanoparticles and nanofibers using the outlined processes and ingredients. We are especially proud of the fact we have been able to use food-grade ingredients in many of the formulations allowing consumer product companies to produce the clean labels consumers are increasingly desiring.”

If you’re long this stock, then you’re liking how the stock has responded to the announcement. CBGL shares have been moving higher over the past week overall, pushing about 14% to the upside on above average trading volume.

Cannabis Global Inc (OTCMKTS:CBGL) just cracked the surface on commercial-stage operations in its last quarterly update. And, given the strong R&D foundation, we could imagine big things ahead if it executes on its current strategy.

Medical Marijuana Inc (OTCMKTS:MJNA) is a chronic loser in the space, but one that can occasionally get hot and run in a spike on some sort of announcement. However, the long-term trajectory has been overpromising, underperformance, and a dilution-filled trip down the chart.

The company operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry.

Medical Marijuana Inc (OTCMKTS:MJNA) recently announced that the Japanese division of its subsidiary Kannaway® had its best month ever in Company history in July 2020.

“Kannaway has made tremendous progress around the world as consumers in Japan and across Asia continue to show an exciting increase in interest for cannabidiol (CBD) products,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our team has truly shown what can be accomplished with passion, hard work and high-quality products designed to support the body’s crucial endocannabinoid system.”

If you’re long this stock, then you’re liking how the stock has responded to the announcement. MJNA shares have been moving higher over the past week overall, pushing about 2% to the upside on above average trading volume. Shares of the stock have powered higher over the past month, rallying roughly 5% in that time on strong overall action.

Medical Marijuana Inc (OTCMKTS:MJNA) managed to rope in revenues totaling $11M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of -46.9%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($5M against $10.5M, respectively).

This article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

Published at Thu, 05 Nov 2020 07:41:42 +0000

B2Digital Inc (OTCMKTS:BTDG) Ready for Two Major MMA Events as PPV Performance Ramps Up

B2Digital Inc (OTCMKTS:BTDG) Ready for Two Major MMA Events as PPV Performance Ramps Up

With all the gloom surrounding the resurgence in pandemic cases and hospitalizations over the past two weeks, it’s easier than ever to lose sight of what’s working.

A case in point – if a surprising one – is the brand being built with great success so far this year for B2Digital Inc (OTCMKTS:BTDG), a rapidly growing OTC player in the live sports media space with a strong focus on Mixed Martial Arts pay-per-view events, branding its niche as the “development league for the MMA”.

It would be easy to assume that live sporting events – even those in the fastest growing sports market – might be suffering over the past couple months. But the story is very much the opposite for BTDG. And the company is looking to put that momentum back to the test again this weekend with two major events: HRMMA 116 in Elizabethtown, Kentucky, on November 6, and Strikehard 57 in Northport, Alabama, on November 7.

The HRMMA 116 event on Friday is also the 12-year Anniversary Show, according to information from the company on social media over recent days.

The momentum is unambiguous, with the company recent setting a new record for pay-per-view viewers in its last event, which follows a string of successful events this fall.

The key here has been an expanding total pool of potential viewers, an innovative marketing initiative, and what appears to be a successful model of running this type of event and distributing it to a widening circle of fans and followers.

A Perfect Storm of Execution?

As noted above, B2Digital Inc (OTCMKTS:BTDG) has benefited in recent months from progress in the company’s execution on multiple fronts.

We have seen a big expansion in distribution reach, with the company adding access to both Amazon Fire TV and Apple TV over the past few weeks, which may have added an addressable OTT market reach of over 70 million new potential viewers, based on data from Ampere Analytics and quoted in the Wall Street Journal earlier this year.

That jump in potential reach comes on the heels of the company’s establishment of its B2InstaStore marketing model, which provides a convenient, fast, and simple way to sign up for the Company’s new B2 Social Media Storefronts platform, where fans and followers can actually get a piece of the action by helping to sell PPV tickets for BTDG events.

According to the company’s release from late August, “The B2 Instastore feature is really something we feel has the potential to revolutionize the live-event PPV marketing game. Imagine all of your fans and followers deciding to become a giant distributed affiliate marketing team helping you sell tickets to your event. The technology is seamless. We are already seeing a strong response. And the timing couldn’t be better – having this system up and fully functional ahead of our first major event in the busy B2 Fighting Series Fall Season carries the potential to provide us with a defining boost in the months ahead.”

In addition, the company has added partners and extra resources on the distribution side, helping to push out a product that minimizes the company’s dependence on in-person audience attendance, which has helped to buffer its model against the uncertainty posed by the pandemic.

Picking Up Steam

Not only are we seeing B2Digital Inc (OTCMKTS:BTDG) maintain its momentum in terms of live MMA events in a challenging context, but we are actually seeing the pace of events pick up, with two major PPV shows scheduled for this coming weekend.

That’s a testament to how the company has navigated the obstacles placed in its path.

One important principle we would highlight – and which we have highlighted frequently in this strange context – is as follows: the companies that manage to thrive through flexible and effective execution during the worst of the pandemic could be poised for significant growth tailwinds as the context normalizes next year. Competition will be thinned out, resources will be accessible on the cheap, and teams will have the momentum that can only come from passing a tough test.

BTDG looks well-situated to find itself in good shape around the corner.

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click here. In addition, this article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

Published at Mon, 02 Nov 2020 03:45:13 +0000

South Dakota Makes History by Passing Both Medical and Adult-Use Cannabis on Same Ballot

South Dakota Makes History by Passing Both Medical and Adult-Use Cannabis on Same Ballot

Editor’s note: Election results reported are projected, and subject to change. CBT/CD will update its election coverage as necessary to accommodate changing election results.

Voters in South Dakota made history on Nov. 3, helping the state become the first in the union to pass a constitutional amendment legalizing adult-use cannabis sales without first having an established medical program.

Amendment A, the constitutional amendment that voters passed on election night with 53.4% of the vote with 95% of precincts reporting, per the Associated Press, legalizes the recreational use of cannabis for adults aged 21 and over and allows the possession of up to one ounce of cannabis per adult. Additionally, the law requires that the state legislature pass laws for a medical cannabis program and for hemp sales no later than April 1, 2022.

The Marijuana Policy Project (MPP) was heavily involved in supporting both ballot measures (Measure 26, the medical cannabis program ballot measure, also passed with 69.2% support). Matthew Schweich, deputy director of the MPP, said in a statement: “South Dakota has made history by becoming the first state to legalize medical marijuana and legalize marijuana for adults on the same day. Furthermore, it is arguably the most conservative state yet to enact marijuana legalization. This victory has added significance at the federal level with top-ranking Republican Senator John Thune now representing a legalization state.”

“What we really support is that it creates two distinct pathways to a shared goal, and it keeps those two pathways separate so that our medical program for our patients will always be there. It will never get absorbed by the adult-use and it puts both of them into the constitution,” Melissa Mentele, executive director of New Approach South Dakota told CBT in August of the medical provisions in Amendment A.

Under the constitutional amendment, municipalities can ban cultivation businesses from operating on its territory, as well as testing facilities, wholesalers, and retail operations. However, if an individual lives in a jurisdiction with no licensed retailers, that person can cultivate up to three plants in a locked space in a private residence.

The amendment also puts into place a 15% excise tax on cannabis sales to consumers. That revenue is to be used to cover the costs of launching and maintaining the amendment, with 50% of the remaining revenue going to the state’s public schools and 50% going into the state’s general fund.

Morgan Fox, media relations director and committee manager for the National Cannabis Industry Association (NCIA), also said in a statement, “South Dakota made history today by becoming the first state to approve a measure regulating cannabis for adults without a preexisting regulated medical cannabis program already in place. Voters should be commended for leading with their hearts and common sense. We encourage the few states where cannabis is still not legal for any purpose to follow South Dakota’s lead and stop punishing responsible adults and seriously ill patients for cannabis, and to providing safe, regulated, and legal methods to obtain it.”

NORML’s Executive Director Erik Altieri said in a statement: “No state has ever moved from marijuana prohibition to allowing both medical use and adult-use access, quite literally, overnight. These votes are a stunning rebuke to those elected officials that for decades have refused to move forward with substantive marijuana law reform legislation, and they are yet another indication of the near-universal popularity of these policy changes among voters in all regions of the United States.”

History in the Making

South Dakota became the first state to place both medical and adult-use measures on the same ballot, as CBT reported in January. With help from MPP, both campaigns coordinated efforts to support one another. At the time, Schweich told CBT that South Dakotans should vote for both ballot initiatives.

“Hopefully, we will pass both initiatives with strong margins and those strong winning margins can serve as a mandate from the people, a message to the legislature that these policies should be implemented in a timely manner,” Schweich told CBT in January. That message stuck, based on the results.

MPP has generally avoided allocating resources toward legislative lobbying in South Dakota, however, as it has proved challenging to get any meaningful bills passed through the legislature.

“Last year, the legislature passed a hemp law and the governor vetoed it,” Schweich said in January. “If they can’t get a hemp law passed, it’s very unlikely that they can get a medical marijuana or adult-use legalization law passed through that legislature, which is conservative and overwhelmingly controlled by the Republican party. So, really, to make progress in South Dakota, a ballot initiative is our only recourse.”

Today, the initiatives’ passage means that both medical and adult-use cannabis now are enshrined in The Mount Rushmore State’s constitution.

Additional reporting by Melissa Schiller

Published at Wed, 04 Nov 2020 14:07:00 +0000

Cannabis Wins Big on Election Night as Five States Pass Legalization Measures

Cannabis Wins Big on Election Night as Five States Pass Legalization Measures

In a historic night for cannabis, all five states with cannabis measures on the ballot in the November 2020 election have voted for either medical or adult-use legalization.  

New Jersey, Arizona and Montana have passed adult-use cannabis legalization, Mississippi has passed medicinal cannabis legalization; and for the first time, one state—South Dakota—passed both medical and adult-use cannabis legalization at the same time.

As it stands today, 35 states have legalized medicinal cannabis, and 15 states have legalized cannabis for adult-use. That means 1 in 3 Americans have access to legal cannabis, according to POLITICO.

RELATED: Cannabis Business Times’ Interactive Legalization Map

“If there was any remaining stigma around cannabis as a form of medicine, it is gone forever,” said Greg Kaufman, partner and co-leader of Eversheds Sutherland’s Cannabis Industry Team, in an emailed statement. “With more states approving adult-use and medical cannabis programs in this election and the expectation that more states will do so through legislation (e.g., New York), the pressure will continue to build on Congress to take some action on one or more of the cannabis-related bills currently pending.”

RELATED: Additional Reading on the SAFE Act and MORE Act

Here is a breakdown of Tuesday’s election results, state by state.

New Jersey

New Jerseyans have voted to approve Public Question No. 1, which amends the state constitution to legalize cannabis for adults aged 21 and over, as well as the cultivation, processing and sale of recreational cannabis products, by a 67-33 margin, according to reporting from the New York Times at 9:10 a.m. ET on Nov. 4.

The amendment to legalize adult-use cannabis will take place on Jan. 1, 2021. Lawmakers are now tasked with determining how the program is run, including restrictions and regulations, and a licensing process. Officials must also establish and appoint members to the state’s Cannabis Regulatory Commission, according to NJ.com. 

Experts anticipate it will be at least a year before adult-use cannabis will be ready for sale, according to Patch.com.

Cannabis industry research firm Brightfield Group projects that an adult-use cannabis market in New Jersey could see more than $352.6 million in sales in 2021, and nearly $649 million in sales the following year.

Industry members anticipate that New Jersey’s legalization may also influence legalization in neighboring states, such as Pennsylvania, New York and Connecticut, and throughout the country.  – Cassie Neiden, editor  

Read more.

Arizona

Despite legal battles and opposition from the state’s governor, Arizona voters approved adult-use cannabis legalization on Election Day by a 60-40 margin, according to unofficial election results reported by the New York Times at 11:19 p.m. ET on Nov. 3.

The statutory measure, Prop. 207, allows adults 21 and older to purchase and possess up to one ounce of cannabis, as well as grow up to six plants at home for personal use.

The Arizona Department of Health, which already regulates the state’s medical cannabis program, is now responsible for overseeing the adult-use industry, which must launch by June 1, 2021, under the initiative.

Cannabis industry research firm Brightfield Group projects that an adult-use cannabis market in Arizona could see more than $288.6 million in sales in 2021, and nearly $857 million in sales the following year, not including medical sales projections. – Melissa Schiller, senior digital editor 

Read more.

Mississippi

Preliminary results from Mississippi show that medical cannabis legalization passed with approximately 67% of the vote, according to the New York Times. Initiative 65, the measure from Mississippians for Compassionate Care’s Medical Marijuana 2020 campaign, received about 48% more votes than a competing measure put on the ballot by the state legislature, Alternative 65A. Roughly 33% of voters were against both measures.

Residents must have one of 22 serious qualifying conditions, such as cancer, chronic pain, or epilepsy, to qualify as a medical cannabis patient—which will be regulated “strictly” by the Mississippi Department of Health, according to Jamie Gratham, Medical Marijuana 2020’s campaign coordinator.

fiscal analysis by Mississippi’s Legislative Budget Office estimates the first year of the medical program will cost the state roughly $11.1 million, according to the Medical Marijuana 2020 site. In the following years, the program will bring in around $10.7 million in overall annual revenue, which will need to go back into the program. – Patrick Williams, senior editor 

Read more.

 

Montana

According to unofficial election results, 59% of Montana voters approved of I-190, the adult-use legalization initiative. Separately, 61% of the Montana electorate voted in favor of the legislature establishing the legal age of adult-use cannabis consumption, a formality. The two ballot initiatives are commonly treated as a package deal.

“This has been a close race in a difficult year, but ultimately good sense prevailed, and Montana will reap the social and economic benefits of legal cannabis while hopefully adding its federal lawmakers to the chorus in Congress calling for an end to federal prohibition,” Morgan Fox, NCIA Media Relations Director, said. – Eric Sandy, digital editor 

Read more.

 

South Dakota

Voters in South Dakota made history on Nov. 3, helping the state become the first in the union to pass a constitutional amendment legalizing adult-use cannabis sales without first having an established medical program.

Amendment A, the constitutional amendment that voters passed on election night with 53.4% of the vote with 95% of precincts reporting, per the Associated Press, legalizes the recreational use of cannabis for adults aged 21 and over and allows the possession of up to one ounce of cannabis per adult. Additionally, the law requires that the state legislature pass laws for a medical cannabis program and for hemp sales no later than April 1, 2022.

Under the constitutional amendment, municipalities can ban cultivation businesses from operating on its territory, as well as testing facilities, wholesalers, and retail operations. However, if an individual lives in a jurisdiction with no licensed retailers, that person can cultivate up to three plants in a locked space in a private residence. – Brian MacIver, senior editor 

Read more.

Published at Wed, 04 Nov 2020 15:02:00 +0000

Fire Engulfs Canopy Growth’s Former Greenhouse Facility in Delta, B.C.

Fire Engulfs Canopy Growth’s Former Greenhouse Facility in Delta, B.C.

VANCOUVER, BC, Nov. 2, 2020 /PRNewswire/ – PRESS RELEASE – Village Farms International, Inc. has announced it has completed the acquisition from Emerald Health Therapeutics, Inc. of 36,958,500 common shares of Pure Sunfarms Corp. owned by Emerald, representing approximately 41.3% of the issued and outstanding common shares of Pure Sunfarms. With the completion of the Pure Sunfarms Transaction, Village Farms now owns 100% of the common shares of Pure Sunfarms. The acquisition of the Pure Sunfarms shares will be immediately accretive to Village Farms’ net income.

“Village Farms conceived of a joint venture to launch its Canadian cannabis business, and the result, Pure Sunfarms, is now one of the leading Canadian cannabis companies. With this transaction our shareholders will now fully benefit from our initiative,” said Michael DeGiglio, CEO of Village Farms. “Pure Sunfarms is well positioned for long-term growth as one of what we believe will be just a small number of major suppliers to the Canadian cannabis market. Importantly, as part of the Village Farms organization Pure Sunfarms can now pursue additional opportunities to further leverage its success to date and increase its earnings potential. I am pleased to welcome the outstanding management team and employees of Pure Sunfarms to our organization, and welcome back so many Village Farms’ personnel who transitioned to our cannabis venture in the early days to ensure that Pure Sunfarms would benefit fully from Village Farms’ decades of experience and site-specific operational expertise. Pure Sunfarms’ CEO, Mandesh Dosanjh, and his entire team have done exceptional work in bringing Village Farms’ vision to reality, and we look forward to their continued contribution to its success as part of Village Farms going forward.

“The acquisition of the entirety of Pure Sunfarms is a defining moment for Village Farms, furthering our transformation to a vertically integrated, plant-based consumer packaged goods company. It allows us to fully leverage the invaluable cannabis expertise Village Farms has gained in combination with the organizational strength underlying the Village Farms produce business to pursue high-growth opportunities in emerging legal cannabis and CBD markets in the United States and targeted markets internationally. We will do so with the same thoughtfulness, prudence, strategic decision making and focus on near-term profitability and long-term return on invested capital that has been fundamental to the success of our investment in Pure Sunfarms.

“We especially look forward to the potential for U.S. regulatory changes that would permit us to pursue our U.S. cannabis aspirations. With one of the largest greenhouse footprints in the U.S., located in one of the best regions for growing in the country, alongside our cannabis success in Canada, we believe there is no company better positioned for long-term success in the U.S. cannabis industry. We are ready to move quickly and aggressively as soon as the regulatory environment permits.”

Upon closing of the Pure Sunfarms transaction, Pure Sunfarms will be fully consolidated in Village Farms’ financial results. Village Farms will report its third quarter financial results and the third quarter financial results of Pure Sunfarms on Nov. 13, 2020. Village Farms’ financial results for the three and nine months ended Sept. 30, 2020 will continue to reflect Village Farms’ 58.7% ownership of Pure Sunfarms as an investment in a joint venture.

Within 75 days of the close, the company is required to file with the U.S. Securities and Exchange Commission, on Form 8-K/A, historical financial statements for Pure Sunfarms, together with unaudited pro forma combined financial statements of the company as if the Pure Sunfarms transaction had occurred on Jan. 1, 2020.

The total purchase price for the Emerald shares of C$79.9 million (US$60.0 million) was satisfied through a C$60.0 million (US$45.0 million) cash payment and a C$19.9 million (US$14.9 million) promissory note due six months from the closing date of the Pure Sunfarms transaction.

Concurrent with the close of the Pure Sunfarms transaction, the existing Pure Sunfarms Shareholders Agreement between Village Farms and Emerald has terminated, as has the Delta 1 – Option to Lease Agreement.

Origin Merchant Partners acted as advisors to Village Farms for the Pure Sunfarms transaction.

Published at Tue, 03 Nov 2020 15:27:00 +0000

Working to Remedy Drug Policy: Q&A with Sarah Gersten, Part 2

Working to Remedy Drug Policy: Q&A with Sarah Gersten, Part 2

This is part two of a two-part interview. Read part one here.

Education and awareness can take many forms. Through various work with criminal justice reform advocates and cannabis businesses, Last Prisoner Project (LPP) aims to shift the paradigm around cannabis incarceration and its effects.

Below, Cannabis Business Times and Cannabis Dispensary continues its conversation with Sarah Gersten, LPP’s executive director and general counsel, about these issues.

Patrick Williams: LPP is working with Rudi Gammo and Michael Thompson in trying to get them released and their criminal records expunged. Could you talk about the Michigan Cannabis Prisoner Release Campaign partnership with the Cannabis Caucus of the Michigan Democratic Party and the Redemption Foundation? Could that work expand upon or accentuate Gov. Gretchen Whitmer’s signage of clean slate bills in October?

Sarah Gersten: This is a campaign that was established after Last Prisoner Project had been working in Michigan for months on Michael Thompson’s case. Michael Thompson is a 69-year-old currently incarcerated in [a] Michigan prison. We had submitted his clemency application in January. We’re just now nearing the finish line with that case, and it took us longer than anticipated, but … we were able to get so much momentum around Michael’s case and really get it into the public [consciousness]. It’s a case that, I think, shocks the conscience, especially when you look at Michigan, a state that is now fully legalized, [and] key lawmakers in that state, like Gov. Whitmer [and] Attorney General Dana Nessel, have come out in support of not just legalization but these kinds of criminal-justice efforts that go in tandem with legalization, like clean slate. But what has not occurred in Michigan, despite movement on things like the clean slate package, which is an amazing first step, [is anything] to provide retroactive release for currently incarcerated cannabis prisoners like Michael Thompson.

So, through Michael Thompson’s case, we started working both with the Redemption Foundation, which was actually started by Ryan Basore, who is an operator in Michigan, but he’s also a former cannabis prisoner—he was incarcerated for years for a nonviolent marijuana offense—as well as the Michigan Cannabis Caucus of the Democratic Party. Working with those local organizations allowed us to work more closely and advocate to the key lawmakers in that state and really broaden these efforts to push forward a campaign to release anyone who is currently incarcerated on marijuana-related offenses in that state. We’ve actually gotten further in Michigan on our clemency program than any other state. I think that speaks to, again, that there is a willingness and a desire by the lawmakers in that state to really bring restorative justice to the cannabis industry and ensure that they’re not legalizing without providing retroactive release for anyone that has been harmed by unjust cannabis laws and policies. But of course, there’s still a lot of work to be done to get to that point. We’ve made a lot of progress, but now we need to push forward to get everyone in that state released.

We’ve … launched the Michigan Cannabis Prisoner Release Campaign. Part of that is working with local companies and fundraising to assist in the legal efforts to secure the release of those still incarcerated in Michigan. But another part of it—what we’re fundraising for—is to actually provide support for those that are still incarcerated. Some of the funding goes directly to their commissary accounts. But another big piece of it is to support their families. Rudi Gammo is a great example. Rudi was actually operating a medical dispensary; he was providing cannabis only to licensed patients. But he was still incarcerated for [a sentence of 5 and a half] years. Obviously, that is extremely detrimental to his family, especially during COVID, to lose someone who’s an earner for their family. Then, on top of that, Rudi’s son was recently diagnosed with leukemia. To be dealing with that, amidst COVID, when you have your father, who’s incarcerated, is just incredibly difficult for his family—devastating for his family. So, part of this fund is also to support family members like Rudi Gammo’s family, who are suffering because they’ve lost a family member due to cannabis prohibition.

PW: The Last Prisoner Project’s policy adviser/director Natalie Papillion, who is also founder and executive director of The Equity Organization, wrote the paper “Criminal Injustice: Cannabis & the Rise of the Carceral State.” There was a portion where she wrote, ‘Drug-related enforcement is one of, if not the, biggest drivers of police harassment, misconduct and violence in America. And yet, drug policy rarely comes up in conversations around police reform.’ Could you talk about why that is?

SG: This is something that I found really interesting coming myself from more of the legal criminal justice sphere and moving into cannabis and cannabis policy. Unfortunately, I really think there is still that same stigma we see just in the public around cannabis. That bleeds into criminal justice reform and I think social justice and racial justice work. There is still sort of a stigma and an unwillingness to focus more narrowly on issues of drug policy reform and certainly, specifically, cannabis reform, which just doesn’t make sense when you’re looking for tangible solutions—because as Natalie articulated in that publication, we know that this is a huge driver of arrest rates, of incarceration rates, in the U.S., but even just interactions with the police.

When you look at some of the most egregious examples of police violence that have been at the forefront of conversations around racial justice and policing reform, particularly over the summer, and when you look at Breonna Taylor’s death, that no-knock warrant that led to her murder was a result of the War on Drugs. The militarization of our police forces is a direct result of the War on Drugs. When we talk about reimagining policing, reinvesting from policing back into communities, dismantling the drug war and dismantling cannabis prohibition should be key solutions that both criminal justice organizations as well as lawmakers should be looking to, to further those initiatives. But we don’t really see that happening. So, that’s a gap that certainly Last Prisoner Project, [and] other organizations like Drug Policy Alliance, are trying to push more into those spheres and to the relevant changemakers.

But I think, when you look at the way that we talk about criminal justice reform, [and] policing reform, more broadly, you don’t often see people calling out cannabis prohibition as a way to rectify those harms. I think more and more, that’s becoming a part of the conversation, especially among certain progressive lawmakers right now, but that is only just beginning. We certainly hope that the work of the Last Prisoner Project, and certainly that study that Natalie published, will help make that more of a central piece of the conversation.

PW: Green Thumb Industries created the video “Waiting to Breathe” about LPP’s reentry coordinator Evelyn LaChapelle, who was incarcerated and now works at Vertosa. Could you talk about how the idea for a video came about as part of a partnership with a cannabis business?

SG: When we partner with cannabis companies, obviously a piece of that is to get financial support for this work; the lifeblood of any nonprofit is funding. But beyond that, a huge thing that we always try to do with partner organizations is raise awareness and educate not only cannabis consumers, but really the broader public. GTI actually came to us with the idea of, [in conjunction] with a big fundraising campaign that they held for Last Prisoner Project in September, … do a really big awareness campaign. One piece of that was the “Waiting to Breathe” video, which I thought was phenomenal in telling Evelyn’s story and why the cannabis industry really has a duty to give back to individuals like Evelyn who have suffered from incarceration for cannabis offenses. But they also had the great educational campaign that was happening on social channels, through digital marketing, but also in their retail locations.

So, in retail locations for September, across all of GTI’s locations, they were highlighting different figures in the cannabis movement, so, people like Brownie Mary [and] Dennis Peron, who were at the forefront of this movement and also intersected not just legalization, but the social justice aspect of legalization—cannabis as medicine for the LGBTQ community, who was suffering with HIV/AIDS. … [They highlighted] the racial justice implications of cannabis legalization and why legalization goes way beyond just having cannabis acceptable as a recreational good, but all of the broader social justice implications that come with legalization, and … different state initiatives, like Prop. 64 in California, as well. So, really the aim of the GTI campaign was to raise awareness of why legalization is a really crucial tool for social justice reform, and highlighting some of the ways that that’s already been occurring across the U.S.

Editor’s Note: This interview has been edited for length and clarity.

Published at Tue, 03 Nov 2020 19:36:00 +0000

Medipharm Labs Is Looking To Capitalize On B2C In A Major Way Through LABS Cannabis

Medipharm Labs Is Looking To Capitalize On B2C In A Major Way Through LABS Cannabis

Early last week, MediPharm Labs (LABS) (MEDIF) reported a major development as it relates to the cannabis 2.0 market and announced the launch of a product line of family of health and wellness called LABS Cannabis. This represents a major change in direction for the business and we have always been favorable on this possibility for it.

MediPharm expects the first product to launch early in the fourth quarter of 2020 and we are bullish on the potential that is associated with the strategy. The premium product line will target Canada’s recreational cannabis market and will distribute products through government and private retail channels.

In late 2018, MediPharm was granted a Sale License from Health Canada and has a proven track record of success in the cannabis concentrate market. The company works out of a sophisticated GMP certified facility and has a reputation of being a best-in-class operator and a global leader in the manufacturing of premium cannabis products.

We expect the LABS Cannabis portfolio to offer premium cannabis products that meet the standards of the most discerning customers. From a consumer standpoint, we like to compare the cannabis industry to the wine industry in the sense that there is a very high-end consumer. These types of consumers want to buy the best products and do not care as much about the cost.

Although the LABS Cannabis portfolio will predominantly include wellness products that are formulated with cannabidiol (CBD), MediPharm plans to have specialized offerings that could also be formulated with tetrahydrocannabinol (THC) and/or other minor cannabinoids that address potential effects. We expect this vertical to lead to margin expansion for MediPharm in 2021 and are bullish on how the story has evolved.

Last year, EY Canada conducted a survey of approx. 3,000 individuals to better understand the perspective of the average Canadian cannabis consumers. A segment of the survey group was referred to as a Wellness Inquisitor who consume almost daily and spend about $165 each per month on cannabis products. If this analysis was expanded and the percentages were used on the entire Canadian population, there would be 1.1 million Wellness Inquisitors. This segment reported that quality (83%) and intended effects (76%) are the most important purchase criteria and believe that MediPharm could be able to capitalize on this population.

Pursuant to an agreement between StoneBridge Partners LLC and Medipharm Labs we have been hired for a period of 180 days beginning August 18, 2020 and ending March 18, 2020 to publicly disseminate information about (LABS) including on the Website and other media including Facebook and Twitter. We are being paid $6,000 per month (LABS) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero (0) shares of (LABS), which we purchased in the open market. We plan to sell the “ZERO” shares of (LABS) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LABS) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Share

Share - Facebook


Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Mon, 02 Nov 2020 16:08:17 +0000

BLGI Inc (OTCMKTS:BLGI) Warms Up as Next-Era Technology Play

BLGI Inc (OTCMKTS:BLGI) Warms Up as Next-Era Technology Play

The scope and scale of the transformation underway in the technology space, and the implications it has for nearly every other industry and domain of 21st century life, is impossible to overestimate. Everything is changing. And the pandemic is markedly accelerating that change.

Pick an industry at random. Education, shipping, manufacturing, healthcare, media, energy, entertainment, finance. They are all in the eye of the hurricane of technological restructuring. That’s the interesting thing about the tech sector: it isn’t a separate sector; it is the foundation for the next version of every other sector.

If you’re a gamer, particularly if you have experience in strategy games, then you know the difference between “weapons” and “skills”. If you get hold of a new cool weapon, you can do some damage with it. But if you augment your “aim” with any weapon, then your character is suddenly more deadly with everything he picks up.

It’s a crude analogy, but it gets to the point. Tech stocks are running so far ahead of the rest of the market over recent months because they represent “skill augmentation” for every other industry, whereas stocks in other sectors simply represent distribution of a good or service.

One new stock that plays heavily into this theme is BLGI Inc (OTCMKTS:BLGI), an emerging software development player trading on the OTC despite having full and exclusive licensing rights from one of the most impressive private blockchain/AI/cloud technology firms around.

The Oncoming Storm

According to information from the company’s communications and website, BLGI Inc (OTCMKTS:BLGI) is attached through licensing agreements to privately held Chicago-based leading-edge software development firm, Charteris, Mackie, Baillie & Cummins Limited (CMBC). CMBC’s primary focus has been, most centrally, the development of commercial solutions for Asset Management for complex financial transactions.

BLGI is also involved in entertainment, music, film, healthcare data, and other manifestations of its core value proposition.

As noted by the company in its July press release: “BLGI has entered into a Software License Agreement with CMBC for the use of its IP that supports the blockchain based development platform that BLGI will commercialize by developing solutions for a broad range of industries. CMBC has also assigned all the rights and benefits to BLGI of the Software License it granted Benchmark Advisors (Bahamas) Limited, a Broker Dealer and Investment Advisor licensed by the Securities Commission of the Bahamas. In exchange for these two transactions BLGI has issued CMBC 294,109,944 shares of common stock.”

This is particularly interesting because BLGI is working to change everything, and it has the team and skills in place to do it.

According to the company’s website, “BLGI is a data science company focusing on developing solutions across a vast spectrum of industries and institutions. We develop cutting edge technology for our clients utilizing machine learning, cloud computing, and Blockchain integration. At BLGI, we provide our clients with bespoke solutions that utilize our Blockchain and Artificial Intelligence (A.I) expertise to expand their company within an ever-changing virtual environment. We provide technical consultation for our clients to develop a plan of action that incorporates BLGI’s licensed and regulated technologies within their systems. Through the integration of these emerging technologies, we provide our clients with an edge over their competitors and empower them to succeed.”

In other words, the company is pushing ahead with specific commercial operations in a few targeted industries. But it is also open for business as a tailored service provider for other firms looking to boost their resources and systems with machine learning (AI), cloud computing, and Blockchain integration.

The Next Era

As noted above, the path from the past to the future goes through AI, cloud, blockchain, and other technological augmentation, for basically every industry.

But the pandemic has actually accelerated the pace of that shift. It was already active before the health crisis, but the time horizon for obviation of non-augmented operations represented a much longer runway.

Now, with the abrupt redefinition of life on this planet that has come with the outbreak, that runway is at an end, and companies are either going to find solutions to take flight, or they will drop off the end of the runway into the ocean and bubble into the depths. It’s do-or-die time for anyone unable to adapt.

BLGI Inc (OTCMKTS:BLGI) is in prime position to take its place in this larger equation given its relationship with CMBC, and its powerful solutions in the most important leading-edge technologies driving the next era.

COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click here. In addition, this article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

Published at Mon, 02 Nov 2020 04:20:01 +0000